These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study. Jain U; Hechtman L; Weiss M; Ahmed TS; Reiz JL; Donnelly GA; Harsanyi Z; Darke AC J Clin Psychiatry; 2007 Feb; 68(2):268-77. PubMed ID: 17335326 [TBL] [Abstract][Full Text] [Related]
28. The effects of stimulant medications for ADHD. Natl Bur Econ Res Bull Aging Health; 2014; (1):1-2. PubMed ID: 25141389 [No Abstract] [Full Text] [Related]
29. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077 [TBL] [Abstract][Full Text] [Related]
30. Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder. Greenhill L; Beyer DH; Finkleson J; Shaffer D; Biederman J; Conners CK; Gillberg C; Huss M; Jensen P; Kennedy JL; Klein R; Rapoport J; Sagvolden T; Spencer T; Swanson JM; Volkow N J Atten Disord; 2002; 6 Suppl 1():S89-100. PubMed ID: 12685523 [TBL] [Abstract][Full Text] [Related]
31. Methylphenidate controlled-delivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attention-deficit hyperactivity disorder. Anderson VR; Keating GM Paediatr Drugs; 2006; 8(5):319-33. PubMed ID: 17037949 [TBL] [Abstract][Full Text] [Related]
32. Questioning the treatment for ADHD. Breggin PR Science; 2001 Jan; 291(5504):595. PubMed ID: 11229399 [No Abstract] [Full Text] [Related]
33. Safety of therapeutic methylphenidate in adults: a systematic review of the evidence. Godfrey J J Psychopharmacol; 2009 Mar; 23(2):194-205. PubMed ID: 18515459 [TBL] [Abstract][Full Text] [Related]
34. Immediate-release methylphenidate for the treatment of ADHD in adults. Kocher J; Adams P Am Fam Physician; 2015 Apr; 91(7):445-6. PubMed ID: 25884744 [No Abstract] [Full Text] [Related]
35. Methylphenidate (Ritalin) use and abuse. Crutchley A; Temlett JA S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063 [No Abstract] [Full Text] [Related]
36. [Methylphenidate. A drug for attention deficit disorders to be used with precaution]. Taéron C Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855 [No Abstract] [Full Text] [Related]
37. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)]. Stasik D; Tucha O; Tucha L; Walitza S; Lange KW Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788 [TBL] [Abstract][Full Text] [Related]
38. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature. Kraemer M; Uekermann J; Wiltfang J; Kis B Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380 [TBL] [Abstract][Full Text] [Related]